Literature DB >> 6262301

Reduction of adriamycin to a semiquinone-free radical by NADPH cytochrome P-450 reductase produces DNA cleavage in a reaction mediated by molecular oxygen.

V Berlin, W A Haseltine.   

Abstract

Adriamycin is reduced to a semiquinone-free radical by microsomal and nuclear enzymes. To investigate the effect of these radicals on DNA, an end-labeled DNA fragment of defined sequence was included in a reaction that contained NADPH, NADPH cytochrome P-450 reductase (EC 1.6.2.4), and adriamycin. Extensive DNA strand scission was observed. The breaks occurred at all nucleotides with equal probability regardless of nucleotide sequence. Single-stranded DNA was as good a substrate as double-stranded DNA for the strand scission reaction. DNA damage occurred during the early phase of the reaction. No strand breaks were observed upon addition of DNA to the reaction 60 min after enzyme activation despite the high concentration of stable free radicals present at this time. The extent of strand scission was greatly reduced when the reaction was carried out in a nitrogen atmosphere. We conclude that DNA breakage created by enzymatically derived adriamycin-free radicals is mediated by molecular oxygen, most probably by hydroxyl-free radicals and hydroxyl ions. We also conclude that the semiquinone-free radicals of adriamycin and radicals of the reduced forms of adriamycin need not intercalate into DNA to create strand breaks.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6262301

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Dissociation of cytotoxicity and DNA cleavage activity induced by topoisomerase II-reactive intercalating agents in hamster-human somatic cell hybrids.

Authors:  B S Glisson; A M Killary; P Merta; W E Ross; J Siciliano; M J Siciliano
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Expression of cytokeratin confers multiple drug resistance.

Authors:  P A Bauman; W S Dalton; J M Anderson; A E Cress
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

3.  Exercise stimulates beneficial adaptations to diminish doxorubicin-induced cellular toxicity.

Authors:  Ashley J Smuder
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-08-28       Impact factor: 3.619

4.  DNA damage and cytotoxicity of mitoxantrone and doxorubicin in doxorubicin-sensitive and -resistant human colon carcinoma cells.

Authors:  L Capolongo; G Belvedere; M D'Incalci
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

5.  Dietary fish oil and vitamin E enhance doxorubicin effects in P388 tumor-bearing mice.

Authors:  Qi-Yuan Liu; Benny K H Tan
Journal:  Lipids       Date:  2002-06       Impact factor: 1.880

Review 6.  Doxorubicin cardiomyopathy.

Authors:  Kanu Chatterjee; Jianqing Zhang; Norman Honbo; Joel S Karliner
Journal:  Cardiology       Date:  2009-12-11       Impact factor: 1.869

7.  Map of distamycin, netropsin, and actinomycin binding sites on heterogeneous DNA: DNA cleavage-inhibition patterns with methidiumpropyl-EDTA.Fe(II).

Authors:  M W Van Dyke; R P Hertzberg; P B Dervan
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

8.  Comparative metabolism and elimination of adriamycin and 4'-epiadriamycin in the rat.

Authors:  T W Sweatman; M Israel
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 9.  Doxorubicin, DNA torsion, and chromatin dynamics.

Authors:  Fan Yang; Sheila S Teves; Christopher J Kemp; Steven Henikoff
Journal:  Biochim Biophys Acta       Date:  2013-12-19

10.  Enhanced antitumor activity of combinations of free and HPMA copolymer-bound drugs.

Authors:  J Hongrapipat; P Kopecková; S Prakongpan; J Kopecek
Journal:  Int J Pharm       Date:  2007-09-22       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.